Our Speakers

Nordic POP 2024 offers Key lectures and Presentations from Senior researchers, Post docs and PhD Students from the Nordic countries. We will continuously present new speakers and lecturers participating in Uppsala 24-26 April 2024.

Our Speakers


Christel BergströmChristel Bergström, Uppsala University (SE)

Christel Bergström is Professor of Molecular Pharmaceutics at Uppsala University and Center Director of National Competence center SweDeliver. In her research, Professor Bergström makes use of knowledge of physiological pathways to improve delivery of pharmacologically active compounds to the site of action.

With a strong background in pharmaceutics, material sciences, physical chemistry and physiology, Professor Bergström makes use of the right tech with a clinical translation in mind from day one. She makes use of advanced computational modelling, develop novel in vitro tools and design new drug carriers in her quest for personalized medicines transforming the current healthcare.

Per Larsson, Uppsala University (SE)Per Larsson, Uppsala University (SE)

Per Larsson is Associate Professor in Peptide Therapeutics at the Department of Pharmacy, Uppsala University. As a Ph.D. student, the focus of his research was on protein structure prediction methods, as well as physics-based simulations. He joined the Department of Pharmacy following post-doctoral studies at the University of Virginia in Charlottesville, USA, where he employed modeling and simulation to understand how peptide-bilayer interactions might facilitate membrane fusion. His research group now uses high-performance physics-based multiscale simulation techniques as well as machine learning to create novel strategies very much needed for improved pharmaceutical formulation design, in particular for peptide therapeutics.

Prof. Larsson is also the leader of the oral drug delivery work package within the National Drug Delivery Competence Center SweDeliver, as well as the leader of the Big Data work package within the NordicPharmaTrain network.

Paola Luciani, University of Bern (CH)Paola Luciani, University of Bern (CH)

Paola Luciani is a Professor of Pharmaceutical Technology at the University of Bern and Director of Study of the Bachelor in Pharmaceutical Sciences. Before relocating to Switzerland, she was Associate Professor for Phospholipids in Drug Development at the Institute of Pharmacy of the University of Jena, Germany. She was recently elected expert of the NANO (Nanomedicine) Working Group by the European Pharmacopeia, EDQM.

Prof. Luciani leads a research group in Pharmaceutical Technology and Drug Delivery working on the design and characterization of lipid-derived and bio-inspired drug delivery systems for the treatment and diagnosis of chronic multifactorial diseases, such as fibrosis, endometriosis and inflammatory diseases. Together with her interdisciplinary team of pharmacists, chemists, biochemists, and engineers, she investigates novel approaches to achieve sustained drug delivery, including additive manufacturing.

Luca Marciani, University of Genoa (IT)Luca Marciani, University of Nottingham (UK)

Luca Marciani, Professor of Gastrointestinal Imaging at University of Nottingham, started working in the field of imaging and spectroscopy in Milan and London, before joining the Sir Peter Mansfield Imaging Centre in Nottingham where he was awarded his Ph.D. in MRI in 2001. After this he translated to the Nottingham Digestive Diseases Centre in the local School of Medicine, where he joined the Faculty in 2010 and was awarded the Chair in Gastrointestinal Imaging in 2020. 

Professor Marciani's personal expertise is in imaging the human gastrointestinal tract using MRI. His research focuses on imaging gastrointestinal function in health and disease using MRI methods in combination with other physiological and behavioral techniques. Current interests include in-body imaging of foods, beverages, drug products and formulations, intestinal fluid distribution and the development of novel MRI tests for motility and transit. He has published 140 papers and 15 book chapters in this area.

Caitriona O’Driscoll​, University College Cork (IE)Caitriona O’Driscoll​, University College Cork (IE)

Caitriona O’Driscoll is Professor and Chair of Pharmaceutics, School of Pharmacy, University College Cork, Ireland. Originally a Pharmacist, Caitriona has over 30 years experience as a drug delivery scientist. Professor O’Driscoll​'s research is focused on the design and delivery of RNA therapeutics for chronic conditions including Crohn’s disease, prostate cancer and neurodegenerative diseases. Targeted delivery to diseased sites is achieved by a non-viral approach using novel biomaterials including modified cyclodextrins.

Professor O’Driscoll​ is the Director of the UCC Future Medicines research initiative. She is also coordinator of Genegut, a Horizon Europe funded project entitled Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease, with 9 partners from 8 different countries.

Jukka Rantanen, University of Copenhagen (DK)Jukka Rantanen, University of Copenhagen (DK)

Jukka Rantanen is Professor of Pharmaceutical technology and engineering at the University of Copenhagen. He received his Ph.D. from the University of Helsinki in 2001, completed a postdoctoral visit at the Dep. of Industrial and Physical Pharmacy at Purdue University (US) in 2003, and joined University of Copenhagen.

Professor Rantanen's research is focusing on development of future manufacturing solutions for medicinal products and especially, molecular-level process analysis of solid dosage forms using spectroscopic techniques combined with multivariate data analysis tools. Professor Rantanen has supervised or is currently supervising 25 Postdocs and Ph.D. students and is an editorial board member of four leading scientific journals within pharmaceutical sciences and chemical engineering.

Niklas Sandler, CurifyLabs (FI)Niklas Sandler, CurifyLabs (FI)

Niklas Sandler is Founder and Chief Technology Officer (CTO) at CurifyLabs, a company transforming personalized drug manufacturing through its digital and automated Pharm Kit platform. CurifyLabs offers a Medicine as a Service concept for pharmacies, hospital pharmacies and veterinarians which saves time, delivers better and sustainable future treatments to pets and humans.

Niklas is an international business-oriented innovative pharmaceutical scientist with experience from various roles both in the pharmaceutical industry and academia. Since 2010 his research has focused on printed drugs in the forefront of shaping the future of pharmaceutical drug manufacturing. Niklas has been invited speaker in numerous pharmaceutical conferences and published his research findings in international high-quality journals throughout the years. He has know-how in late stage pharmaceutical product development and research in pharmaceutical technology and has experience of leading process engineering activities and various material science projects in the pharmaceutical industry and academia. Between 2009 and 2019 Niklas was Professor in Pharmaceutical Technology at Åbo Akademi University and possesses experience in material science, process engineering, tech transfer, IPR and early commercialisation of technology products derived from research. His  research projects have focused on new production techniques and quality control technologies for medicines employing additive manufacturing (3D printing) e.g. by inkjet, fused deposition modeling and pressure assisted extrusion technologies. Niklas has published approximately 100 papers in major international peer-reviewed journals since 2000. In his role as Vice Rector for Åbo Akademi university Niklas initiated and lead several strategic development activities of the organization. Between 2019-2022 he was Chief Technology Officer at Nanoform Finland Ltd.

Alexandra Stubelius, Chalmers University of Technology (SE)Alexandra Stubelius, Chalmers University of Technology (SE)

Alexandra Stubelius is an Associate Professor in Nanomedicine at Chalmers University of Technology.  After receiving her Master’s degree in Pharmacy and a Ph.D. in Medicine from the University of Gothenburg, Dr. Stubelius undertook postdoctoral research at UCSD Center of Excellence for Nanomedicine in San Diego, USA.

Prof. Stubelius was recruited to Chalmers in 2019 where her lab develops nanomedicines for immune-related disorders, integrating the synthesis of materials with their analysis in biological contexts. She was awarded the only starting grant in Precision Medicine from the Swedish Research Council and The Hasselblad Award for Female Scientists, to name a few. She serves on scientific boards including CRS Nordic Local Chapter, is a PI of NordicPOP, and a work-package leader in NordicPharmaTrain.

Maria Tenje, Uppsala University (SE)Maria Tenje, Uppsala University (SE)

Maria Tenje is a Professor of Microsystems Technology at Uppsala University. She received her PhD degree from the Technical University of Denmark in 2007 on the topic of mechanical biosensors. Professor Tenje is currently Head of the Division of Biomedical Engineering and Director of the MedTech Science and Innovation Centre, both at Uppsala University.

Professor Tenje also leads the EMBLA group (Enabling Microtechnologies for Biomedical and Life science Applications), comprising researchers with backgrounds in material science, nanotechnology, chemistry and biology. Research activities of EMBLA are focused on organs-on-chip models and droplet microfluidics. These projects have an interdisciplinary character and use microfabrication techniques combined with microfluidics to develop new platforms to learn more about the human biology.

Shiqi Wang, University of Helsinki (FI)Shiqi Wang, University of Helsinki (FI)

Dr. Shiqi Wang received her Master degree from Tsinghua University China in 2014. Then she moved to Imperial College London as a Marie Curie Early Stage Researcher, where she got her Ph.D. degree in 2018. She then joined University of Helsinki's Faculty of Pharmacy as a postdoctoral researcher, before starting her own research group at the same Faculty.

Dr. Wang’s research interests include developing pH-responsive polymeric materials for intracellular drug delivery applications. She is a co-author of 60 peer-reviewed papers, with >3600 citations in total (h-index=28) and receiver of numerous awards and grants, including an ERC starting grant, Academy of Finland Fellowship, and Finnish Pharmaceutical Society most outstanding research article award.

Our Program

Last modified: 2024-03-13